

S3 Ep52: The Original "Baby Lung": PARDS with PedsCrit
8 snips Jun 1, 2022
Dr. Nadir Yehya, an expert in pediatric respiratory failure at CHOP, shares invaluable insights on managing pediatric Acute Respiratory Distress Syndrome (ARDS). He delves into the complexities of pediatric ARDS, contrasting it with adult cases and discussing unique diagnostic criteria. The conversation touches on innovative approaches to ventilation strategies and the importance of individualized care. Dr. Yehya also discusses treatment disparities in different regions and emphasizes the need for continued research into long-term recovery in children.
AI Snips
Chapters
Books
Transcript
Episode notes
A Tenfold Medication Error
- As a resident, Nadir Yehya made a tenfold medication error, causing a patient's kidneys to shut down and leading to intubation.
- The experience taught him to question his certainty when other qualified professionals raise concerns.
Pediatric vs. Adult ARDS
- Pediatric ARDS, while similar to adult ARDS, has key differences, including a lower mortality rate and potentially a less robust inflammatory response.
- Neonatal RDS is distinct, primarily a surfactant deficiency issue, further complicating comparisons.
PALIC Definition of Pediatric ARDS
- Pediatric ARDS is defined by acute onset (within 7 days), new opacities on imaging, non-hydrostatic pulmonary edema, and oxygenation criteria.
- Use oxygenation index (OI) and SpO2-based equivalents for severity stratification in intubated patients.